The Psychedelics Newsletter, Issue 91

Braving the Bear Market - Investment in?Psychedelic Healthcare

There are strong signs Europe and North America are about to enter a recession, as sanctions against Russian oil and supply chain disruption exacerbate inflation.?

In response to soaring inflation, the Federal Reserve has raised interest rates three times in six months – with further hikes expected.?

High interest rates make it harder for companies to raise the capital that finances research and development, a core activity in life sciences.?

This has resulted in company valuations and investment plummeting; however, the bear market presents lucrative opportunities for investors who can weather the storm.

READ MORE

US ADMINISTRATION ANTICIPATES PSYCHEDELIC THERAPY IN 2 YEARS

The government is exploring the creation of a task force to monitor the emerging psychedelic healthcare?ecosystem.

READ MORE

NZ GOVERNMENT GRANTS MINDBIO THERAPEUTICS NZ$1.4M

The funding was provided to conduct a LSD microdosing trial in patients with Major Depressive Disorder.

READ MORE

BUSINESS AND INVESTMENT

• The race to?develop psychedelic medicines.
• The safety?of psychedelic healthcare.
• Field Trip doses first patient in?Phase I trial.
• Small Pharma granted patent for?injectable DMT formulation.?
• Unregulated?psilocybin market thriving.
• Ketamine-assisted therapy for?substance use disorder.
• Virtual reality and?psychedelic-assisted therapy.
• Australian health fund provides cover?for psychedelic medicine.

The Psychedelics as Medicine Report?provides market intelligence from industry experts and thought leaders.

Previous?sponsors include atai Life Sciences, COMPASS Pathways and Cybin.

Contact?[email protected]?for partnership opportunities.

SCIENCE AND RESEARCH

• Restrictions on?psychedelic research easing.
• The use of psychedelic?medicines in psychiatry
• Psilocybin induces desynchronised cortical?activity in rodents.

REGULATION AND LEGISLATION

• A DEA reverses decision to?schedule novel tryptamines.
• DEA sued over delays on?Freedom of Information requests.